TSXV:CLAS.H - Post by User
Comment by
MyKnighton Feb 28, 2020 11:27am
85 Views
Post# 30747112
RE:Kalytera is on the verge of legacy
RE:Kalytera is on the verge of legacy Just to add,
For me this is also a no Brainer, Over 650 Millions planet wise only for POST GVHD.
People forget that their's a market of over a Billions on year 1 for POST GVHD.
Big pharma won't forget does number when buying us.....
Kaly will also cover this markte eventually.... which would mean over a Billilons a year
Kalytera is on the verge of legacy
1 - First to have Fda approved GVHD treatment 2- Life threatening condition 3- Urgent unmet need for treatment 4- 408 million a year and up to 1.3 billion a year by 2027 No other company on the market is positioned this way, plus thats only the GVHD not to mention there pain drug there working on. Anyway Im holding this gem for a couple a years for sure or until a big pharma company buy us out. For me this is a no brainer, Hold for profit. Cheers